Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.8 USD | +0.72% |
|
+5.04% | -15.59% |
07-15 | Morgan Stanley Raises Price Target on Inari Medical to $60 From $55, Keeps Overweight Rating | MT |
07-01 | Inari Medical, Inc.(NasdaqGS:NARI) dropped from Russell 3000E Value Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.59% | 3.19B | |
+75.69% | 12.57B | |
-23.80% | 7.43B | |
-7.11% | 5.79B | |
+6.54% | 5.09B | |
+17.15% | 4.2B | |
-15.15% | 4.13B | |
-2.72% | 2B | |
+20.50% | 1.94B | |
-4.11% | 1.72B |
- Stock Market
- Equities
- NARI Stock
- News Inari Medical, Inc.
- Morgan Stanley Raises Price Target on Inari Medical to $60 From $55, Keeps Overweight Rating